Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × niraparib × Other solid neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1 Gynecologic 1 Classical hematology 1

Conditions

Solid Tumor 2 Mesothelioma, Malignant 2 Mesothelioma 2 Advanced Solid Tumor 2 Uveal Melanoma 1 Solid Tumor, Adult 1 Recurrence 1 MMR-D/MSI-H Colorectal Cancers 1 Cholangiocarcinoma 1 Carcinoma, Renal Cell 1 Advanced Solid Tumors 1 Advanced Solid Tumor, Adult 1

Interventions

vandetanib 1 niraparib 1 alvocidib 1 Vinorelbine 1 Topotecan 1 Sirolimus 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05455424 2025-05-15

NERO

University Hospital Southampton NHS Foundation Trust

Phase 2 Completed

Other solid neoplasmThoracic

Mesothelioma, Malignant, Mesothelioma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡